TrademarkOpen
Search / United States / 97646752

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark / Service Mark

AND

Allowed — statement of use stage
Fourth Extension - Granted
Used for: Biological and chemical agents for scientific use other than for medical use, namely, addressable and programmable…
Show more

Class 1: Biological and chemical agents for scientific use other than for medical use, namely, addressable and programmable protein-based therapeutics
Class 5: Biological therapeutics, namely, addressable and programmable protein-based therapeutics, including multi-specific polypeptide-based therapeutics, namely, therapeutic pharmaceuticals for the treatment of genetic diseases and disorders, genomic diseases and disorders, hematological disorders, hormonal disorders, infectious diseases, reproductive disorders, metabolic disorders, orthopedic conditions, musculoskeletal diseases and disorders, gastrointestinal diseases and disorders, immune system-related diseases and disorders, dermatological diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, cancer, diabetes, and respiratory diseases and disorders…
Class 42: Drug development services, namely, pharmaceutical drug development services; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products, namely, pharmaceutical drug development services; pharmaceutical and biotech research and development, namely, pharmaceutical drug development services

Class 1 – ChemicalsClass 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaS

Status timeline

  1. 26 May 2023
    Assigned to an examining attorney
    Assigned To Examiner
  2. 27 May 2023
    Office action issued
    Non-Final Action Written
  3. 22 Aug 2023
    Response to office action filed
    Teas Response To Office Action Received
  4. 23 Aug 2023
    Ownership assignment recorded
    Automatic Update Of Assignment Of Ownership
  5. 24 Oct 2023
    Final refusal issued
    Final Refusal Mailed
  6. 20 Jan 2024
    Approved for publication
    Approved For Pub - Principal Register
  7. 27 Feb 2024
    Published for opposition
    Published For Opposition
  8. 23 Apr 2024
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  9. 18 Oct 2024
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  10. 12 Mar 2025
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  11. 22 Oct 2025
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
All 44 events
2026-02-27Notice Of Approval Of Extension Request E-Mailed
2026-02-26Sou Teas Extension Received
2026-02-26Sou Extension 4 Filed
2026-02-26Sou Extension 4 Granted
2025-10-23Notice Of Approval Of Extension Request E-Mailed
2025-10-22Sou Teas Extension Received
2025-10-22Sou Extension 3 Filed
2025-10-22Sou Extension 3 Granted
2025-03-13Notice Of Approval Of Extension Request E-Mailed
2025-03-12Sou Teas Extension Received
2025-03-12Sou Extension 2 Filed
2025-03-12Sou Extension 2 Granted
2025-01-07Teas Change Of Owner Address Received
2025-01-07Applicant/Correspondence Changes (Non-Responsive) Entered
2025-01-07Teas Change Of Correspondence Received
2024-10-18Sou Teas Extension Received
2024-10-18Sou Extension 1 Filed
2024-10-18Sou Extension 1 Granted
2024-10-18Notice Of Approval Of Extension Request E-Mailed
2024-04-23Noa Mailed - Sou Required From Applicant
2024-03-04Official Gazette Publication Confirmation E-Mailed
2024-02-27Published For Opposition
2024-02-07Notification Of Notice Of Publication E-Mailed
2024-02-07Official Gazette Publication Confirmation E-Mailed
2024-01-20Approved For Pub - Principal Register
2024-01-19Teas/Email Correspondence Entered
2024-01-18Teas Change Of Owner Address Received
2024-01-18Applicant/Correspondence Changes (Non-Responsive) Entered
2024-01-18Teas Change Of Correspondence Received
2024-01-18Teas Request For Reconsideration Received
2024-01-18Correspondence Received In Law Office
2023-10-24Final Refusal Mailed
2023-10-24Final Refusal E-Mailed
2023-10-24Notification Of Final Refusal Emailed
2023-10-04Assignment Of Ownership Not Updated Automatically
2023-08-23Automatic Update Of Assignment Of Ownership
2023-08-22Teas Response To Office Action Received
2023-08-22Correspondence Received In Law Office
2023-08-22Teas/Email Correspondence Entered
2023-05-27Non-Final Action Written
2023-05-27Non-Final Action E-Mailed
2023-05-27Notification Of Non-Final Action E-Mailed
2023-05-26Assigned To Examiner
2022-11-08New Application Office Supplied Data Entered

Goods & services by class

Class 1 Chemicals

Biological and chemical agents for scientific use other than for medical use, namely, addressable and programmable protein-based therapeutics

Class 5 Pharmaceuticals & supplements

Biological therapeutics, namely, addressable and programmable protein-based therapeutics, including multi-specific polypeptide-based therapeutics, namely, therapeutic pharmaceuticals for the treatment of genetic diseases and disorders, genomic diseases and disorders, hematological disorders, hormonal disorders, infectious diseases, reproductive disorders, metabolic disorders, orthopedic conditions, musculoskeletal diseases and disorders, gastrointestinal diseases and disorders, immune system-related diseases and disorders, dermatological diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, cancer, diabetes, and respiratory diseases and disorders…

Class 42 Technology & SaaS

Drug development services, namely, pharmaceutical drug development services; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products, namely, pharmaceutical drug development services; pharmaceutical and biotech research and development, namely, pharmaceutical drug development services

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 28 Feb 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.